These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Methotrexate for maintenance of remission in IgG4-related disease. Della-Torre E; Campochiaro C; Bozzolo EP; Dagna L; Scotti R; Nicoletti R; Stone JH; Sabbadini MG Rheumatology (Oxford); 2015 Oct; 54(10):1934-6. PubMed ID: 26139657 [No Abstract] [Full Text] [Related]
23. Methotrexate: the agent of choice for chronic inflammatory disorders. A perspective ten years later. Gutiérrez-Ureña S; Espinoza LR Clin Exp Rheumatol; 1995; 13(3):281-4. PubMed ID: 7554552 [No Abstract] [Full Text] [Related]
25. [Methotrexate: safe if prescribed correctly]. Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A Ned Tijdschr Geneeskd; 2009; 153():A695. PubMed ID: 19785857 [TBL] [Abstract][Full Text] [Related]
26. Methotrexate embryopathy after exposure to low weekly doses in early pregnancy. Martín MC; Barbero P; Groisman B; Aguirre MÁ; Koren G Reprod Toxicol; 2014 Jan; 43():26-9. PubMed ID: 24513926 [TBL] [Abstract][Full Text] [Related]
27. [Use of NSAIDs in rheumatoid arthritis should be limited]. Lindberg M Ugeskr Laeger; 2013 Apr; 175(15):1039-41. PubMed ID: 23582126 [TBL] [Abstract][Full Text] [Related]
28. Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update. Duarte AC; Santos-Faria D; Gonçalves MJ; Sepriano A; Mourão AF; Duarte C; Neves JS; Águeda AF; Ribeiro PA; Daniel A; Neto A; Cordeiro A; Rodrigues A; Barcelos A; Silva C; Ponte C; Vieira-Sousa E; Teixeira F; Oliveira-Ramos F; Araújo F; Barcelos F; Canhão H; Santos H; Ramos J; Polido-Pereira J; Tavares-Costa J; Melo Gomes JA; Cunha-Miranda L; Costa L; Cerqueira M; Cruz M; Santos MJ; Bernardes M; Oliveira P; Abreu P; Figueira R; Barros R; Falcão S; Pinto P; Pimenta S; Capela S; Teixeira V; Fonseca JE Acta Reumatol Port; 2017; 42(2):127-140. PubMed ID: 28535545 [TBL] [Abstract][Full Text] [Related]
29. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Whittle SL; Hughes RA Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort. Müller RB; von Kempis J; Haile SR; Schiff MH Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697 [TBL] [Abstract][Full Text] [Related]
31. Safety of less frequent monitoring of liver transaminases levels in rheumatic patients treated with low-dose methotrexate. Khabbazi A; Kolahi S; Dastgiri S; Hajialiloo M; Nazeri M; Nazeri L; Sheikholeslami Salmasi A; Gader S; Bak Mohammad Zadeh S; Ghasemi A; Poormohammad A Int J Rheum Dis; 2014 Jul; 17(6):646-52. PubMed ID: 24965662 [TBL] [Abstract][Full Text] [Related]
32. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis. Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036 [TBL] [Abstract][Full Text] [Related]
33. Update on methotrexate as the anchor drug for rheumatoid arthritis. Pincus T; Gibson KA; Castrejón I Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S9-19. PubMed ID: 24219036 [TBL] [Abstract][Full Text] [Related]
34. [Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?]. Glück T; Müller-Ladner U Dtsch Med Wochenschr; 2007 Sep; 132(37):1901-4. PubMed ID: 17823884 [No Abstract] [Full Text] [Related]
35. [The use of methotrexate in rheumatology: results and prospects]. Nasonov EL Klin Med (Mosk); 1996; 74(5):10-5. PubMed ID: 8999172 [No Abstract] [Full Text] [Related]
36. [Hypertransaminemia and methotrexate: not always a toxic effect?]. Montilla Morales C; López Longo FJ; Moreno Zazo M; Monteagudo Sáez I; Moreno García AC; Carreño Pérez L Rev Clin Esp; 1998 Dec; 198(12):822-4. PubMed ID: 9930004 [TBL] [Abstract][Full Text] [Related]
37. Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and design. Hillson JL; Furst DE Rheum Dis Clin North Am; 1997 Nov; 23(4):757-78. PubMed ID: 9361154 [TBL] [Abstract][Full Text] [Related]
38. The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis. Ruderman EM Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S29-32. PubMed ID: 24219038 [TBL] [Abstract][Full Text] [Related]
39. [Trends in the treatment of rheumatic diseases]. Trotta F; Padovan M Recenti Prog Med; 1999 Oct; 90(10):510-4. PubMed ID: 10592735 [No Abstract] [Full Text] [Related]
40. Corticosteroids as disease modifying drugs in rheumatoid arthritis treatment. Yazici Y Bull NYU Hosp Jt Dis; 2012; 70 Suppl 1():11-3. PubMed ID: 23259652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]